Get startedLog in
    Picture of Medicus Pharma logo

    MDCX — Medicus Pharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Medicus Pharma Announces Skinject® Phase 2 Principal Investigator And Key Opinion Leader (Kol), Babar K. Rao MD, Faad, To Provide Clinical Interpretation Of Positive Data During Business Update Webcast On March 26

    Picture of Medicus Pharma logoMedicus Pharma
    16/03/2026 11:38
    March 16 (Reuters) - Medicus Pharma Ltd MDCX.O:

MEDICUS PHARMA ANNOUNCES SKINJECT® PHASE 2 PRINCIPAL INVESTIGATOR AND KEY OPINION LEADER (KOL), BABAR K. RAO MD, FAAD, TO PROVIDE CLINICAL INTERPRETATION OF POSITIVE DATA DURING BUSINESS UPDATE WEBCAST ON MARCH 26

Source text: ID:nGNXsZWQP

Further company coverage: MDCX.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Medicus Pharma

    See all news